ICD-10-CM Billable Code

E04.0

Nontoxic diffuse goiter

Clinical Classification Guidelines

Inclusion Terms

  • Diffuse (colloid) nontoxic goiter
  • Simple nontoxic goiter

Medical Intelligence & Overview

Nontoxic diffuse goiter, also known as simple or colloid goiter, is a condition characterized by an enlarged thyroid gland without the presence of overproduction of thyroid hormones. The goiter develops gradually and typically does not produce symptoms related to thyroid hormone excess or deficiency. This condition is often identified during routine medical examinations or imaging studies. While it can be benign and manageable, understanding its causes, symptoms, diagnosis, and treatment options can help patients better comprehend the condition.

Causes & Symptoms

Clinical Causes: Iodine deficiency: A widespread cause, especially in regions with insufficient iodine in the diet. Hashimoto's thyroiditis: An autoimmune disorder that may initially cause goiter before progressing to hypothyroidism. Genetic factors: Family history can predispose individuals to develop goiters. Environmental factors: Exposure to certain chemicals or goitrogens (substances that interfere with thyroid function). Other autoimmune or inflammatory conditions of the thyroid, which can cause enlargement without hormone overproduction.

Key Symptoms: Gradual swelling at the base of the neck Feeling of fullness or tightness in the throat Difficulties swallowing or breathing in larger goiters Few or no symptoms if the goiter is small Absence of symptoms related to hyperthyroidism (such as rapid heartbeat, weight loss) or hypothyroidism (such as fatigue, weight gain)

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of physical examination and diagnostic tests. During an examination, a healthcare provider assesses the neck for swelling and consistency. Additional tests may include: - Thyroid function tests (measuring TSH, T3, T4 levels): These often show normal hormone levels in nontoxic goiters. - Thyroid ultrasound: Provides detailed imaging of the thyroid gland and helps assess the size and texture. - Radioactive iodine uptake test: Determines how much iodine the thyroid is taking up, which helps distinguish different types of goiter. - Fine-needle aspiration biopsy: May be performed if there is suspicion of nodules or other abnormalities.

Treatment Protocols: In many cases, nontoxic diffuse goiter does not require immediate treatment if it is small and not causing symptoms. Management options include: - Observation: Regular monitoring for growth or development of symptoms. - Iodine supplementation: If deficiency is identified as a cause. - Thyroid hormone therapy: Sometimes used to reduce the size of the goiter or prevent further growth. - Surgery: Considered if the goiter causes significant symptoms, compresses adjacent structures, or if there is suspicion of malignancy. - Addressing underlying causes: Such as autoimmune conditions or environmental factors contributing to the enlargement.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E04.0 a billable ICD-10 code?
Yes, E04.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E04.0?
Clinical documentation must specify the nature of Nontoxic diffuse goiter and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

nontoxic diffuse goiter